Results of Annual Screening in Phase I of the United Kingdom Familial Ovarian Cancer Screening Study Highlight the Need for Strict Adherence to Screening Schedule
ROSENTHAL, Adam N, FRASER, Lindsay, GARETH EVANS, D, ECCLES, Diana M, SKATES, Steven J, MACKAY, James, MENON, Usha, JACOBS, Ian J, MANCHANDA, Ranjit, BADMAN, Philip, PHILPOTT, Susan, MOZERSKY, Jessica, HADWIN, Richard, CAFFERTY, Fay H, BENJAMIN, Elizabeth, SINGH, Naveena
Published in Journal of clinical oncology (01.01.2013)
Published in Journal of clinical oncology (01.01.2013)
Get full text
Journal Article
Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study
Rosenthal, Adam N, Fraser, Lindsay S M, Philpott, Susan, Manchanda, Ranjit, Burnell, Matthew, Badman, Philip, Hadwin, Richard, Rizzuto, Ivana, Benjamin, Elizabeth, Singh, Naveena, Evans, D Gareth, Eccles, Diana M, Ryan, Andy, Liston, Robert, Dawnay, Anne, Ford, Jeremy, Gunu, Richard, Mackay, James, Skates, Steven J, Menon, Usha, Jacobs, Ian J
Published in Journal of clinical oncology (01.05.2017)
Published in Journal of clinical oncology (01.05.2017)
Get full text
Journal Article
Circulating tumour DNA dynamics during alternating chemotherapy and hormonal therapy in metastatic breast cancer: the ALERT study
Allsopp, Rebecca C., Guo, Qi, Page, Karen, Bhagani, Shradha, Kasim, Anna, Badman, Philip, Kenny, Laura, Stebbing, Justin, Shaw, Jacqueline A.
Published in Breast cancer research and treatment (01.07.2024)
Published in Breast cancer research and treatment (01.07.2024)
Get full text
Journal Article
REFINE-Lung implements a novel multi-arm randomised trial design to address possible immunotherapy overtreatment
Ghorani, Ehsan, Quartagno, Matteo, Blackhall, Fiona, Gilbert, Duncan C, O'Brien, Mary, Ottensmeier, Christian, Pizzo, Elena, Spicer, James, Williams, Alex, Badman, Philip, Parmar, Mahesh K B, Seckl, Michael J
Published in The lancet oncology (01.05.2023)
Published in The lancet oncology (01.05.2023)
Get full text
Journal Article
Immune modulation and the oral live biotherapeutic product, MRx0518, in treatment-naïve patients with cancer: Updated safety data
Lythgoe, Mark, Dama, Paola, Frampton, Adam Enver, Pickford, Emily, Tookman, Laura, Cunnea, Paula, Fotopoulou, Christina, Liu, Daniel, Clark, James, Lozano-kuehne, Jingky, Badman, Philip David, Clarke, Aaron, Chetal, Sasha, Fyvie, Gayle, Stevenson, Alex, Krell, Jonathan
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
REFINE-Lung: A multicentre phase III study to determine the optimal frequency of pembrolizumab in non-small cell lung cancer utilising a novel multi-arm design
Seckl, Michael, Ghorani, Ehsan, Quartagno, Matteo, Blackhall, Fiona Helen, Gilbert, Duncan C., O'Brien, Mary E.R., Ottensmeier, Christian H.H, Pizzo, Elena, Spicer, James F., Williams, Alex, Badman, Philip David, Parmar, Mahesh K. B.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
204 REFINE-Lung is a multicentre phase III study to determine the optimal frequency of pembrolizumab in advanced non-small cell lung cancer (NSCLC) utilising a novel multi-arm design
Ghorani, Ehsan, Quartagno, Matteo, Blackhall, Fiona, O'Brien, Mary, Ottensmeier, Christian, Pizzo, Elena, Spicer, James, Gilbert, Duncan, Baker, Alex, Badman, Philip, Milner-Watts, Charlotte, D. d'Arienzo, Paolo, Dangoor, Adam, Adhikaree, Jason, Evans, Joanne, Leite, Pollyanna, Keni, Manjusha, Steele, Nicola, Gomes, Fabio, Gomez-Randulfe, Igor, Belitei, Petru, Stewart, Grant, Barrie, Colin, Geldart, Tom, Jain, Pooja, Liu, Justin KH, Zubairi, Ishtaiq, Muthukumar, Dakshinamoorthy, Gray, Lucy, Treece, Sarah, Aleksic, Aleksandar, Tsaknis, Georgios, Rathbone, Emma, Shaw, Paul, Tarver, Kathryn, Parmar, Mahesh K.B., Seckl, Michael J.
Published in Lung cancer (Amsterdam, Netherlands) (01.04.2024)
Published in Lung cancer (Amsterdam, Netherlands) (01.04.2024)
Get full text
Journal Article
RADICAL trial: A phase Ib/IIa study to assess the safety and efficacy of AZD4547 in combination with either anastrozole or letrozole in ER positive breast cancer patients progressing on these aromatase inhibitors (AIs)
Seckl, Michael, Badman, Philip David, Liu, Xinxue, MacPherson, Iain R., Zubairi, Ishtiaq Husain, Baird, Richard D., Garcia-Corbacho, Javier, Cresti, Nicola, Plummer, Elizabeth R., Armstrong, Anne Caroline, Allerton, Rozenn, Landers, Donal, Nicholas, Hanna, McLellan, Lyndall, Lim, Adrian K., Coombes, Charles
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Final results of 4-monthly screening in the UK Familial Ovarian Cancer Screening Study (UKFOCSS Phase 2)
Rosenthal, Adam N, Fraser, Lindsay, Philpott, Susan, Manchanda, Ranjit, Badman, Philip, Hadwin, Richard, Evans, D. Gareth, Eccles, Diana, Skates, Steven James, Mackay, James, Menon, Usha, Jacobs, Ian
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article